How is Cerebrolysin administered?
This describes how Cerebrolysin is typically administered in clinical and research references, not a self-administration guide. The usual route is Intramuscular or IV (medical), sub-q used by some community users, on a daily during course schedule, generally over 10-30 day courses. Specific dosing is individual and beyond general information, and human evidence for Cerebrolysin is limited.
Administration at a glance (reference data)
- Route: Intramuscular or IV (medical), sub-q used by some community users
- Schedule: Daily during course
- Cycle length: 10-30 day courses
- Half-life: Variable (peptide mixture)
References
- Cerebrolysin in acute ischemic stroke, Cochrane review — Ziganshina LE et al., Cochrane Database Syst Rev, 2020
- Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study — Khasanova DR et al., BMC Neurology, 2023
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Cerebrolysin
Last updated 2026-06-15.